Innovent, Xuanzhu Collaborate on Clinical Trial for Advanced Solid Tumors in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

December 28, 2023 | Thursday | News
Elpiscience, Astellas Partner on Bispecific Macrophage Engager

The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up to two...

December 28, 2023 | Thursday | News
Senti Bio Receives FDA Clearance for SENTI-202 in Hematologic Malignancies

Initial clinical efficacy data expected by year-end 2024 and durability data expected in 2025 – – SENTI-202 is a potential first-in-class of...

December 26, 2023 | Tuesday | News
AlloVir Updates Phase 3 Program for Posoleucel T Cell Therapy

Company to discontinue its three Phase 3 posoleucel studies following separate, pre-planned DSMB futility analyses concluding the studies were unlikely to ...

December 26, 2023 | Tuesday | News
JCR and Alexion Partner on Oligonucleotide Therapeutics Using J-Brain Cargo® Technology

-JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida: “JCR”) announces that it has signed a Research Collaboration, Op...

December 22, 2023 | Friday | News
FDA Approves Label Update for Yescarta® CAR T-Cell Therapy with Overall Survival Data

Kite, a Gilead Company (Nasdaq: GILD), announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Yescarta® (axicabtage...

December 22, 2023 | Friday | News
Multiply Labs and Akron Bio Collaborate to Automate cGMP-Compliant Liquid Cytokines in Cell Therapy Manufacturing

Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and Akron Bio (“Akron&...

December 21, 2023 | Thursday | News
Atomic AI Optimizes RNA Therapeutic Development with Chemical Mapping Data

Atomic AI’s ATOM-1 large language model (LLM) demonstrates state-of-the-art accuracy for predicting RNA structure and function Technology can be exp...

December 18, 2023 | Monday | News
Candel Therapeutics' CAN-2409 Granted FDA Fast Track for Pancreatic Cancer

“We are pleased with the FDA's decision to grant Fast Track Designation for CAN-2409 in pancreatic cancer,” said Paul Peter Tak, MD, PhD, FMedS...

December 12, 2023 | Tuesday | News
RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™

RoslinCT, a cell and gene therapy Contract Development and Manufacturing Organisation (‘CDMO’) dedicated to developing therapies for patients w...

December 11, 2023 | Monday | News
Codexis KOL Event Underscores Demand for Enzymatic RNAi Therapeutics Synthesis

“As part of the pioneering team that established RNAi therapeutics as a whole new class of medicines, I am thrilled to see the field advance with six...

December 11, 2023 | Monday | News
EnGeneIC's Novel cGranted FDA Fast-Track Designation

Pancreatic ductal adenocarcinoma (PDAC) is a notoriously challenging and aggressive form of cancer, usually diagnosed in advanced stages, making curative t...

December 08, 2023 | Friday | News
Taiwan Bio and TRACT Therapeutics Partner for Novel Solid Organ Transplant Therapy

This partnership leverages Taiwan Bio’s world-class expertise in cellular therapy manufacturing and TRACT Therapeutics’ innovative immune modul...

December 07, 2023 | Thursday | News
ShiraTronics Launches First-Ever Trial for Chronic Migraine Therapy in Australia.

This development underscores the company's commitment to advancing innovative solutions that provide relief and improved quality of life for the millions o...

November 30, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close